Welcome to the SCC

We are an educational and scientific society of
qualified physicians and other professionals
dedicated to the promotion, protection and
support of cannabis for medical use.

 

Best Practices

for integrity and standards of practice

 

Sharing Knowledge

in the medical community

 

Real Doctors

helping real people

1
1

Latest Posts

in Alzheimer's Disease

Cannabidiol Modulates the Expression of Alzheimer’s Disease-Related Genes in Mesenchymal Stem Cells.

Authors: Rosaliana Libro, Francesca Diomede, Domenico Scionti, Adriano Piattelli, Gianpaolo Grassi, Federica Pollastro, Placido Bramanti, Emanuela Mazzon, Oriana Trubiani Published in International Journal of Molecular Sciences 23 December 2016  …
Read More
in Neurodegenerative

Endocannabinoid system in neurodegenerative disorders.

Authors: Balapal S. Basavarajappa, Madhu Shivakumar, Vikram Joshi, Shivakumar Subbanna Published in Journal of Neurochemistry September 2017   Abstract Most neurodegenerative disorders (NDDs) are characterized by cognitive impairment and other…
Read More
in Dementia

Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview.

Authors: Rosaliana Libro, Sabrina Giacoppo, Thangavelu Soundara Rajan, Placido Bramanti, Emanuela Mazzon Published in Molecules 21 April 2016   Abstract The word dementia describes a class of heterogeneous diseases which…
Read More
in Alzheimer's Disease

Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic.

Authors: Ester Aso, Isidre Ferrer Published in Frontiers in Pharmacology 5 March 2014   Abstract The limited effectiveness of current therapies against Alzheimer's disease (AD) highlights the need for intensifying…
Read More
in Alzheimer's Disease

A molecular link between the active component of marijuana and Alzheimer’s disease pathology.

Authors: Lisa M. Eubanks, Claude J. Rogers, George F. Koob, Arthur J. Olson, Tobin J. Dickerson, Kim D. Janda Published in Molecular Pharmaceutics 2006   Abstract Alzheimer's disease is the…
Read More
in Allergy

Cannabis sativa: the unconventional “weed” allergen.

Authors: Thad L. Ocampo, Tonya S. Rans Published in Annals of Allergy, Asthma & Immunology March 2015   Abstract Introduction Passage of legislation in Washington, Colorado, Oregon, Alaska, and the…
Read More
in ADHD

Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial.

Authors: Ruth E. Cooper, Emma Williams, Seth Seegobin, Charlotte Tye, Jonna Kuntsi, Philip Asherson Published in European Neuropsychopharmacology August 2017   Abstract Adults with ADHD describe self-medicating with cannabis, with…
Read More
in Psychiatric Problems

Targeting the Endocannabinoid System in Psychiatric Illness.

Authors: Martin A. Katzman, Melissa Furtado, Leena Anand Published in Journal of Clinical Psychopharmacology December 2016   Abstract Prevalence of psychiatric disorders continues to rise globally, yet remission rates and…
Read More
in ADHD

The impact of ADHD persistence, recent cannabis use, and age of regular cannabis use onset on subcortical volume and cortical thickness in young adults.

Authors: Krista M. Lisdahl, Leanne Tamm, Jeffery N. Epstein, Terry Jernigan, Brooke S. G. Molina, Stephen P. Hinshaw, James M. Swanson, Erik Newman, Clare Kelly, James M. Bjork, MTA Neuroimaging…
Read More
in ADHD

Association of the cannabinoid receptor gene (CNR1) with ADHD and post‐traumatic stress disorder.

Authors: Ake T. Lu, Matthew N. Ogdie, Marjo‐Ritta Järvelin, Irma K. Moilanen, Sandra K. Loo James T. McCracken, James J. McGough, May H. Yang, Leena Peltonen, Stanley F. Nelson Rita…
Read More
in News

Member Meeting: Pregnancy & Breastfeeding

The next SCC Member Meeting is scheduled for Sunday, March 3 at 12 noon (pacific time) This is a virtual meeting via Zoom. The topic is: Cannabis Use in Pregnancy and…
Read More
in News

SCC Announces Hiring of An Executive Director

Ellen Kuwana, a skilled science communicator, will serve as SCC’s first-ever Executive Director. Ms. Kuwana will help the SCC continue to offer outstanding CME and other evidence-based information. Ms. Kuwana…
Read More
in Cannabinoids, CBD, Conditions, Epilepsy, General Information, News, Research, Research Articles, Seizure Disorder

Epidiolex Weighs in at Schedule V

But CBD remains on Schedule I, due to its supposed abuse liability.  “DEA’s decision to move Epidiolex to Schedule V…  applies only to CBD products approved by the FDA. Other,…
Read More
in Alzheimer's Disease, Brain Trauma, Cancer, Conditions, Epilepsy, News, Parkinson's, Research, Research Articles

Russo’s Grand Unified Theory

Ethan Russo forwards his paper, Grand Unified Theory (GUT): The Endcannabinoid System, Cannabis and the Microbiome just published in Frontiers of Integrative Neuroscience. Russo notes: “This article addresses five critical…
Read More
in Cannabinoids, News

Meiri Publishes in Nature

Joe D. Goldstrich, MD, forwards a groundbreaking paper by Dr. David Meiri and colleagues at the Technion in Haifa, just published by Nature. Goldstrich comments: “In this seminal study, Dr.…
Read More

CME and Membership for Physicians and Allied Professionals

Study the science behind and clinical application of medical cannabis with a focus on the endocannabinoid system, delivery and dosage – 5.5 CME or 13 AAFP Elective credits

Become a member of the SCC and enjoy all the knowledge, resources and benefits of being part of the growing community of medicinal cannabis professionals around the globe.

Newsletter Sign-Up

Sign up for weekly cutting edge news from O’Shaughnessy’s, an independent partner of the SCC, ranging from cannabis research, breaking news, and educational offerings.